Recently, the National Medical Products Administration has given the nod for the market launch of two groundbreaking medical devices. The carbon dioxide angiography pressure injection set, crafted by Amed Medical Devices (Beijing) Co., Ltd., encompasses an angiographic syringe, infusion tubing, and a dual-lock filter. Designed for injecting high-purity carbon dioxide into various locations, including renal and iliac arteries, for angiographic procedures, this device is an ideal choice for patients who are allergic to iodinated contrast agents, suffer from chronic kidney disease (stages III to V), or have hyperthyroidism.

Meanwhile, the transcatheter mitral valve repair system, developed by InPulse Medical Technology (Shanghai) Co., Ltd., comprises a mitral valve clip and catheter delivery system, along with a steerable guiding catheter. Utilizing a percutaneous method, this system is tailored for patients with degenerative mitral regurgitation (MR≥3+) who are deemed high-risk candidates for surgical intervention and possess suitable mitral valve anatomy.